Display Settings:

Format

Send to:

Choose Destination

    Br J Ophthalmol. 2002 Feb;86(2):156-8.

    Sildenafil induces retinal vasodilatation in healthy subjects.

    Pache M, Meyer P, Prünte C, Orgül S, Nuttli I, Flammer J.

    University Eye Clinic Basel, Switzerland.

    BACKGROUND: The cardiovascular effects of sildenafil (Viagra), a selective inhibitor of phosphodiesterase type 5 (PDE5), have been extensively studied. However, its effect on human retinal arteries and veins has not yet been investigated. The effect of a single dose administration of sildenafil on the retinal vessel diameters of healthy subjects was evaluated. METHODS: Sildenafil 50 mg was administered to 10 healthy subjects (male:female = 4:6; mean age 31 (SD 6) years). The diameters of retinal arteries and veins were measured by means of a retinal vessel analyser (RVA) immediately before and at 30, 60, 90, and 120 minutes after sildenafil uptake. Blood pressure, heart rate, and intraocular pressure were monitored in parallel. RESULTS: A significant increase of 5.8% (p<0.001) in both retinal arterial and venous diameters was found 30 minutes after sildenafil uptake. The diameters returned to baseline after 120 minutes. A mild systemic hypotensive response was seen. Changes in heart rate and intraocular pressure were not observed. CONCLUSION: Sildenafil causes a significant dilatation of retinal arteries and veins in healthy subjects. A possible role for PDE5 in the regulation of retinal blood flow is implicated.

    PMID: 11815339 [PubMed - indexed for MEDLINE]

    PMCID: 1771001

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Sildenafil (Revatio®, Viagra®)

      Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil (Revatio) is used to improve the ability to exercise in people with pulmonary arterial hypert...